Graduate
David Stern has been appointed chief commercial officer at Celmatix, a privately held, New York City-based pharmaceutical company focused on fertility. Previously, he was executive vice president, global commercial operations at OvaScience.
David Stern has been appointed chief commercial officer at Celmatix, a privately held, New York City-based pharmaceutical company focused on fertility. Previously, he was executive vice president, global commercial operations at OvaScience.